IMATINIB MESYLATE 400 MG TAB

imatinib mesylate
$3.2150per EA
High Outlier

Strength

400 mg/1

NDC

68001049104

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

2/18/2026

Active Ingredients

IMATINIB MESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA078340

On Market Since

3/26/2021

Pharmacological Classes

Bcr-Abl Tyrosine Kinase Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Kinase Inhibitor

Price History

1W

0.0%

1M

0.0%

3M

+0.9%

6M

+7.8%

1Y

+16.2%

3Y

+38.2%

5Y

N/A

All

-5.0%